A new modification of the writing syndrome.
D000632:Aminopyrine / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001095:Arachidonic Acids / Q000037:antagonists & inhibitors; D003061:Codeine / Q000494:pharmacology; D005663:Furans; D006027:Glycosides; D007274:Injections, Intraperitoneal; D008297:Male; D051379:Mice; D009020:Morphine / Q000494:pharmacology; D009269:Nalorphine / Q000494:pharmacology; D010423:Pentazocine / Q000494:pharmacology; D010615:Phenacetin / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D012980:Sodium Salicylate / Q000494:pharmacology; D013035:Spasm / Q000139:chemically induced*
D000893:Anti-Inflammatory Agents; D001095:Arachidonic Acids; D005663:Furans; D006027:Glycosides; D000632:Aminopyrine; D009020:Morphine; D010615:Phenacetin; D010653:Phenylbutazone; D010423:Pentazocine; D009269:Nalorphine; D003061:Codeine; D012980:Sodium Salicylate